ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Fluorescence-aided stereotactic needle biopsies for brain tumors: experience on 516 cases.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn patients affected by central nervous system tumors not amenable to surgical resection, stereotactic needle biopsy today represents the only available diagnostic approach. Achieving a high diagnostic yield is essential for timely therapeutic decision-making. This study investigates the impact of intraoperative fluorophores (sodium fluorescein and 5-aminolevulinic acid) use on the diagnostic accuracy of stereotactic brain biopsies.
methodsWe retrospectively analyzed 516 stereotactic brain biopsies performed between 2015 and 2024. Data collected included fluorophore use, technique employed, histopathological and molecular results, and procedural outcomes. Diagnostic yield was defined as the proportion of conclusive diagnoses, in accordance with updated WHO classification criteria, while an extended definition, referred to as diagnostic success, included incomplete diagnoses; conversely, diagnostic failure was defined as inconclusive diagnosis. Statistical analyses included Chi-square testing and logistic regression.
resultsFluorophores were used in 314 procedures (60.9%), while 202 (39.1%) were done without (control group). The diagnostic yield was 76.1% with fluorophores versus 68.8% without. When including incomplete diagnoses (diagnostic success) the accuracy rose up to 93.3% in the fluorophore group versus 78.2% in the control group. Fluorophore use was associated with a 69.3% relative reduction in diagnostic failure (p < .001). Logistic regression confirmed that fluorophores significantly increased the odds of diagnostic success (OR = 3.89, p < .001), without significant histology-based selection bias.
conclusionIntraoperative fluorophores application significantly enhances diagnostic yield in stereotactic brain biopsies, independently of tumor histology. These results support a wider implementation of fluorescence-guided biopsy techniques to improve diagnostic accuracy in neuro-oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.